Given the solid evidence supporting the role of both the complement and B cells, pathogenetic mechanisms of post-transplant FSGS recurrence may involve primary complement system activation, which stimulates excessive BAFF secretion by neutrophils, resulting in a B cell-mediated damage to the glomerular barrier. This evidence concerns the gene TNFSF13B and focal segmental glomerulosclerosis.